年轻成年乳腺癌幸存者的医疗保健利用和随访护理。

IF 4.6 3区 医学 Q1 ONCOLOGY
Shakirah N Ssebyala, Yue Zheng, Elizabeth Riley, Kathryn J Ruddy, Rulla M Tamimi, Jeffrey M Peppercorn, Lidia Schapira, Steven E Come, Virginia F Borges, Ann H Partridge, Shoshana M Rosenberg
{"title":"年轻成年乳腺癌幸存者的医疗保健利用和随访护理。","authors":"Shakirah N Ssebyala, Yue Zheng, Elizabeth Riley, Kathryn J Ruddy, Rulla M Tamimi, Jeffrey M Peppercorn, Lidia Schapira, Steven E Come, Virginia F Borges, Ann H Partridge, Shoshana M Rosenberg","doi":"10.1200/OP-25-00288","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Given the extended survivorship of young adults with breast cancer, characterizing health care utilization and adherence to surveillance guidelines can inform gaps in care.</p><p><strong>Patients and methods: </strong>Patients age 40 years and younger at diagnosis of stage 0-III breast cancer enrolled in a prospective cohort study completed a survey 7 years after diagnosis assessing receipt of care and surveillance. We evaluated factors associated with transition to a primary care provider (PCP) for cancer-related follow-up and adherence to mammography and bone density scans.</p><p><strong>Results: </strong>Among 660 women, 92% reported having a PCP, although for cancer-related follow-up, 57% saw only an oncology provider, 29% saw both a PCP and oncology provider. In the past 2 years, 68% reported getting a flu shot, 76% a pap test/pelvic examination, 56% cholesterol screening, and 42% (n = 232 endocrine therapy [ET] users) a bone density scan. Among women who had a unilateral mastectomy or lumpectomy (n = 356), 82% reported a mammogram in the past year. In multivariate analyses, those with stage 0 (<i>v</i> I disease) were more likely to see a PCP for follow-up (<i>v</i> PCP + oncology provider); ET users and those more concerned about recurrence were less likely. Patients with human epidermal growth factor receptor 2-positive (HER2) disease were more likely to adhere to mammography; those with a <i>BRCA</i> mutation and those with a unilateral mastectomy were less likely. Patients with a <i>BRCA</i> mutation and who had chemotherapy were more likely to report a bone density scan.</p><p><strong>Conclusion: </strong>Although most have a PCP, over half of young survivors continue to see an oncology provider for follow-up in long-term survivorship. Mammography uptake was high; uptake of other health maintenance practices was lower. Identification of barriers/facilitators to receipt of guideline-concordant care may inform strategies to optimize survivorship.</p>","PeriodicalId":14612,"journal":{"name":"JCO oncology practice","volume":" ","pages":"OP2500288"},"PeriodicalIF":4.6000,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Health Care Utilization and Follow-Up Care in Young Adult Breast Cancer Survivors.\",\"authors\":\"Shakirah N Ssebyala, Yue Zheng, Elizabeth Riley, Kathryn J Ruddy, Rulla M Tamimi, Jeffrey M Peppercorn, Lidia Schapira, Steven E Come, Virginia F Borges, Ann H Partridge, Shoshana M Rosenberg\",\"doi\":\"10.1200/OP-25-00288\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Given the extended survivorship of young adults with breast cancer, characterizing health care utilization and adherence to surveillance guidelines can inform gaps in care.</p><p><strong>Patients and methods: </strong>Patients age 40 years and younger at diagnosis of stage 0-III breast cancer enrolled in a prospective cohort study completed a survey 7 years after diagnosis assessing receipt of care and surveillance. We evaluated factors associated with transition to a primary care provider (PCP) for cancer-related follow-up and adherence to mammography and bone density scans.</p><p><strong>Results: </strong>Among 660 women, 92% reported having a PCP, although for cancer-related follow-up, 57% saw only an oncology provider, 29% saw both a PCP and oncology provider. In the past 2 years, 68% reported getting a flu shot, 76% a pap test/pelvic examination, 56% cholesterol screening, and 42% (n = 232 endocrine therapy [ET] users) a bone density scan. Among women who had a unilateral mastectomy or lumpectomy (n = 356), 82% reported a mammogram in the past year. In multivariate analyses, those with stage 0 (<i>v</i> I disease) were more likely to see a PCP for follow-up (<i>v</i> PCP + oncology provider); ET users and those more concerned about recurrence were less likely. Patients with human epidermal growth factor receptor 2-positive (HER2) disease were more likely to adhere to mammography; those with a <i>BRCA</i> mutation and those with a unilateral mastectomy were less likely. Patients with a <i>BRCA</i> mutation and who had chemotherapy were more likely to report a bone density scan.</p><p><strong>Conclusion: </strong>Although most have a PCP, over half of young survivors continue to see an oncology provider for follow-up in long-term survivorship. Mammography uptake was high; uptake of other health maintenance practices was lower. Identification of barriers/facilitators to receipt of guideline-concordant care may inform strategies to optimize survivorship.</p>\",\"PeriodicalId\":14612,\"journal\":{\"name\":\"JCO oncology practice\",\"volume\":\" \",\"pages\":\"OP2500288\"},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2025-09-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JCO oncology practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1200/OP-25-00288\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JCO oncology practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1200/OP-25-00288","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:考虑到年轻乳腺癌患者的生存期延长,确定医疗保健利用和对监测指南的遵守情况可以为护理方面的差距提供信息。患者和方法:在一项前瞻性队列研究中,年龄在40岁及以下的0-III期乳腺癌患者在诊断后7年完成了一项调查,评估了接受治疗和监测的情况。我们评估了转移到初级保健提供者(PCP)进行癌症相关随访和坚持乳房x光检查和骨密度扫描的相关因素。结果:在660名女性中,92%的人报告有PCP,尽管在癌症相关的随访中,57%的人只看了肿瘤医生,29%的人同时看了PCP和肿瘤医生。在过去的两年里,68%的人接种了流感疫苗,76%的人做了巴氏试验/盆腔检查,56%的人做了胆固醇筛查,42%的人(232名内分泌治疗[ET]使用者)做了骨密度扫描。在接受单侧乳房切除术或乳房肿瘤切除术的女性(n = 356)中,82%报告在过去一年中进行了乳房x光检查。在多变量分析中,0期(v I期)患者更有可能看到PCP进行随访(v PCP +肿瘤学提供者);ET使用者和那些更担心复发的人不太可能。人表皮生长因子受体2阳性(HER2)疾病患者更有可能坚持乳房x光检查;携带BRCA基因突变和单侧乳房切除术的患者患乳腺癌的可能性较小。患有BRCA突变并接受化疗的患者更有可能报告骨密度扫描。结论:尽管大多数人都有PCP,但超过一半的年轻幸存者在长期生存期间继续接受肿瘤医生的随访。乳房x线摄影摄率高;其他保健做法的接受程度较低。识别接受指南一致性护理的障碍/促进因素可能为优化生存策略提供信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Health Care Utilization and Follow-Up Care in Young Adult Breast Cancer Survivors.

Purpose: Given the extended survivorship of young adults with breast cancer, characterizing health care utilization and adherence to surveillance guidelines can inform gaps in care.

Patients and methods: Patients age 40 years and younger at diagnosis of stage 0-III breast cancer enrolled in a prospective cohort study completed a survey 7 years after diagnosis assessing receipt of care and surveillance. We evaluated factors associated with transition to a primary care provider (PCP) for cancer-related follow-up and adherence to mammography and bone density scans.

Results: Among 660 women, 92% reported having a PCP, although for cancer-related follow-up, 57% saw only an oncology provider, 29% saw both a PCP and oncology provider. In the past 2 years, 68% reported getting a flu shot, 76% a pap test/pelvic examination, 56% cholesterol screening, and 42% (n = 232 endocrine therapy [ET] users) a bone density scan. Among women who had a unilateral mastectomy or lumpectomy (n = 356), 82% reported a mammogram in the past year. In multivariate analyses, those with stage 0 (v I disease) were more likely to see a PCP for follow-up (v PCP + oncology provider); ET users and those more concerned about recurrence were less likely. Patients with human epidermal growth factor receptor 2-positive (HER2) disease were more likely to adhere to mammography; those with a BRCA mutation and those with a unilateral mastectomy were less likely. Patients with a BRCA mutation and who had chemotherapy were more likely to report a bone density scan.

Conclusion: Although most have a PCP, over half of young survivors continue to see an oncology provider for follow-up in long-term survivorship. Mammography uptake was high; uptake of other health maintenance practices was lower. Identification of barriers/facilitators to receipt of guideline-concordant care may inform strategies to optimize survivorship.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
6.40
自引率
7.50%
发文量
518
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信